A higher percentage of ERα-positive breast tumor samples that we analyzed revealed a high level of CLOCK protein compared to ERα-negative breast tumor samples (74% versus 46%, Fig.1B), which suggested that the transcription of CLOCK in ERα-positive tumor may be upregulated. The gene discussed is ESR1; the disease is breast neoplasm.